XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Sep. 27, 2025
Dec. 28, 2024
Current assets:    
Cash and cash equivalents $ 207,097 $ 194,606
Trade receivables and contract assets, net of allowances for credit losses of $13,805 and $18,301, respectively 734,482 720,915
Inventories 302,550 278,544
Prepaid assets 121,535 103,210
Other current assets 166,440 105,796
Total current assets 1,532,104 1,403,071
Property, plant and equipment, net 1,591,625 1,604,014
Venture capital and strategic equity investments 194,635 218,350
Operating lease right-of-use assets, net 374,273 412,490
Goodwill 2,922,281 2,846,608
Intangible assets, net 571,094 723,400
Deferred tax assets 36,907 42,179
Other assets 290,893 278,233
Total assets 7,513,812 7,528,345
Current liabilities:    
Accounts payable 169,615 140,337
Accrued compensation 269,697 179,418
Deferred revenue 237,728 248,322
Accrued liabilities 228,895 232,010
Other current liabilities 215,953 194,014
Total current liabilities 1,121,888 994,101
Long-term debt, net and finance leases 2,185,453 2,240,205
Operating lease right-of-use liabilities 443,185 483,789
Deferred tax liabilities 123,007 106,960
Other long-term liabilities 189,462 195,212
Total liabilities 4,062,995 4,020,267
Commitments and contingencies (Notes 10, 12, and 14)
Redeemable noncontrolling interests 40,492 41,126
Equity:    
Preferred stock, $0.01 par value; 20,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value; 120,000 shares authorized; 51,351 shares issued and 49,215 shares outstanding as of September 27, 2025, and 51,141 shares issued and outstanding as of December 28, 2024 514 511
Additional paid-in capital 2,015,665 1,966,237
Retained earnings 1,944,317 1,812,100
Treasury stock, at cost, 2,136 and zero shares, as of September 27, 2025 and December 28, 2024, respectively (363,431) 0
Accumulated other comprehensive loss (191,616) (317,345)
Total Charles River Laboratories International, Inc. equity 3,405,449 3,461,503
Nonredeemable noncontrolling interest 4,876 5,449
Total equity 3,410,325 3,466,952
Total liabilities, redeemable noncontrolling interests and equity $ 7,513,812 $ 7,528,345